Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.

Scientific Reports
Sandra MarijanVedrana Čikeš Čulić

Abstract

Glycosphingolipid expression differs between human breast cancer stem cells (CSC) and cancer non-stem cells (non-CSC). We performed studies of viability, type of cell death, cancer stem cell percent and glycosphingolipid expression on CSC and non-CSC after treatment of MDA-MB-231 and MDA-MB-453 triple-negative breast cancer cells with a newly developed thienopyridine anticancer compound (3-amino-N-(3-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide, 1). Compound 1 was cytotoxic for both breast cancer cell lines and the majority of cells died by treatment-induced apoptosis. The percent of cancer stem cells and number of formed mammospheres was significantly lower. Glycosphingolipids IV6Neu5Ac-nLc4Cer and GalNAc-GM1b (IV3Neu5Ac-Gg5Cer) not reported previously, were identified in both CSCs and non-CSCs. IV6Neu5Ac-nLc4Cer had increased expression in both CSCs and non-CSCs of both cell lines after the treatment with 1, while GM3 (II3Neu5Ac-LacCer) had increased expression only on both cell subpopulations in MDA-MB-231 cell line. GalNAc-GM1b, Gb4Cer (GalNAcβ1-3Galα1-4Galβ1-4Glcβ1-1Cer) and GM2 (II3Neu5Ac-GalNAcβ1-4Galβ1-4Glcβ1-1Cer) were increased only in CSCs of both cell lines while GD3 was decrea...Continue Reading

References

Nov 15, 2001·The Journal of Biological Chemistry·Seiichi TagamiYasuyuki Igarashi
Sep 1, 1963·Journal of Neurochemistry·L SVENNERHOLM
Mar 23, 2005·Biochemical and Biophysical Research Communications·Anita MarkotićJohannes Müthing
Aug 12, 2008·Bioorganic & Medicinal Chemistry Letters·Jason D HughesYao Zhang
Mar 24, 2009·Bioorganic & Medicinal Chemistry·Jóhannes ReynissonSuzanne A Eccles
Apr 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Feng GuanSen-itiroh Hakomori
Dec 24, 2010·BJU International·Ashley E RossMilena Vuica-Ross
May 1, 2012·Nature Reviews. Drug Discovery·Michael M Hann, György M Keserü
Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yuh-Jin LiangSen-itiroh Hakomori
Oct 15, 2014·Journal of Cellular and Molecular Medicine·Francesca MargheriGabriella Fibbi
Jan 24, 2015·Glycoconjugate Journal·Sen-Itiroh Hakomori, Kazuko Handa
Dec 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Sarah K C CheungChi-Huey Wong
Jan 29, 2016·Methods in Molecular Biology·Xuanmao JiaoRichard G Pestell
Feb 27, 2016·Journal of Cellular Biochemistry·Seog-Young KimYong J Lee
Jul 31, 2016·Journal of Translational Medicine·M MiyanJ de Boniface
Mar 30, 2017·Drug Design, Development and Therapy·Angela MastelićAnita Markotić
Dec 12, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jiahui WuChangyan Ma
Dec 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ayesha ZafarJóhannes Reynisson
Jan 2, 2018·Maturitas·Lena BluemelChristof Bernemann
Feb 13, 2018·Translational Oncology·Tao ZuoChen Wu
Sep 19, 2018·International Journal of Medical Microbiology : IJMM·Nadine LegrosJohannes Müthing
Mar 28, 2019·Cell Reports·Deepthi RaghuAmy N Abell
Aug 20, 2019·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Saghar YousefniaMohammad Hossein Nasr Esfahani
Feb 27, 2020·International Journal of Molecular Sciences·Wey-Ran Lin, Chau-Ting Yeh

❮ Previous
Next ❯

Citations

Mar 17, 2021·Bioorganic & Medicinal Chemistry·Natalie A HaverkateDavid Barker
Jun 15, 2021·ACS Omega·Tatyana A StroganovaGennady D Krapivin

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
glycosylation
flow-cytometry

Software Mentioned

GraphPad Prism
FlowLogic

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis